Menu
GeneBe

rs200944014

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001036.6(RYR3):ā€‹c.4548C>Gā€‹(p.Ser1516Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,591,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1516N) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.000046 ( 0 hom., cov: 33)
Exomes š‘“: 0.00013 ( 0 hom. )

Consequence

RYR3
NM_001036.6 missense

Scores

5
9
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.00
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.9

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RYR3NM_001036.6 linkuse as main transcriptc.4548C>G p.Ser1516Arg missense_variant 34/104 ENST00000634891.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RYR3ENST00000634891.2 linkuse as main transcriptc.4548C>G p.Ser1516Arg missense_variant 34/1041 NM_001036.6 P4Q15413-1
RYR3ENST00000389232.9 linkuse as main transcriptc.4548C>G p.Ser1516Arg missense_variant 34/1045 A1
RYR3ENST00000415757.7 linkuse as main transcriptc.4548C>G p.Ser1516Arg missense_variant 34/1032 A2Q15413-2
RYR3ENST00000634418.1 linkuse as main transcriptc.4548C>G p.Ser1516Arg missense_variant 34/1025

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000109
AC:
23
AN:
211240
Hom.:
0
AF XY:
0.000132
AC XY:
15
AN XY:
113702
show subpopulations
Gnomad AFR exome
AF:
0.0000825
Gnomad AMR exome
AF:
0.0000652
Gnomad ASJ exome
AF:
0.000107
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000387
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000192
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000126
AC:
181
AN:
1439646
Hom.:
0
Cov.:
32
AF XY:
0.000129
AC XY:
92
AN XY:
713586
show subpopulations
Gnomad4 AFR exome
AF:
0.0000302
Gnomad4 AMR exome
AF:
0.0000480
Gnomad4 ASJ exome
AF:
0.0000389
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000610
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000148
Gnomad4 OTH exome
AF:
0.000101
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152176
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74326
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000882
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000135
Hom.:
0
Bravo
AF:
0.0000642
ExAC
AF:
0.0000911
AC:
11

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Epileptic encephalopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeSep 07, 2022In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 530987). This variant has not been reported in the literature in individuals affected with RYR3-related conditions. This variant is present in population databases (rs200944014, gnomAD 0.02%). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 1516 of the RYR3 protein (p.Ser1516Arg). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Pathogenic
0.23
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.71
D;.;.;.;.
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.22
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.90
D;D;D;D;D
M_CAP
Pathogenic
0.59
D
MetaRNN
Pathogenic
0.90
D;D;D;D;D
MetaSVM
Pathogenic
0.81
D
MutationAssessor
Uncertain
2.3
M;M;.;.;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.67
T
Polyphen
0.93
P;P;.;.;.
Vest4
0.92
MutPred
0.42
Gain of MoRF binding (P = 0.0311);Gain of MoRF binding (P = 0.0311);Gain of MoRF binding (P = 0.0311);Gain of MoRF binding (P = 0.0311);Gain of MoRF binding (P = 0.0311);
MVP
0.94
MPC
0.45
ClinPred
0.43
T
GERP RS
3.9
Varity_R
0.60
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200944014; hg19: chr15-33952550; API